K230694 is an FDA 510(k) clearance for the NaviCam Xpress Stomach System, NaviCam Xpress System. This device is classified as a Magnetically Maneuvered Capsule Endoscopy System (Class II - Special Controls, product code QKZ).
Submitted by Anx Robotica Corp (Plano, US). The FDA issued a Cleared decision on April 13, 2023, 31 days after receiving the submission on March 13, 2023.
This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.1310. A Magnetically Maneuvered Capsule Endoscopy System Consists Of An Ingestible Capsule And Magnetic Controller And Is Used For Visualization Of The Stomach And Duodenum. The Ingestible Capsule Contains A Camera That Wirelessly Captures Images Of The Mucosa. The Magnetic Controller Is Used Outside Of The Patient And Is Magnetically Coupled With The Capsule To Control Its Location And Viewing Direction..
| 510(k) Number | K230694 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | March 13, 2023 |
| Decision Date | April 13, 2023 |
| Days to Decision | 31 days |
| Submission Type | Special |
| Review Panel | Gastroenterology & Urology (GU) |
| Summary | Summary PDF |
| Product Code | QKZ - Magnetically Maneuvered Capsule Endoscopy System |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 876.1310 |
| Definition | A Magnetically Maneuvered Capsule Endoscopy System Consists Of An Ingestible Capsule And Magnetic Controller And Is Used For Visualization Of The Stomach And Duodenum. The Ingestible Capsule Contains A Camera That Wirelessly Captures Images Of The Mucosa. The Magnetic Controller Is Used Outside Of The Patient And Is Magnetically Coupled With The Capsule To Control Its Location And Viewing Direction. |